Commercial cytokine assay on equine cerebrospinal fluid does not distinguish equine degenerative myeloencephalopathy from cervical vertebral stenotic myelopathy
American Journal of Veterinary Research · 2025
DOI: 10.2460/ajvr.25.06.0212 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2025. Verfasst von Flavie Payette und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Studies, School of Veterinary Medicine, New Bolton Center, University of Pennsylvania, Kennett Square, PA. Hauptthemen laut MEDLINE: Horse Diseases, Cytokines, Spinal Stenosis, Spinal Cord Compression. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To measure and compare CSF cytokine concentrations among horses with equine neuroaxonal dystrophy (eNAD)/equine degenerative myeloencephalopathy (EDM), horses with cervical vertebral stenotic myelopathy (CVSM), and control horses and to evaluate for associations with clinical parameters.
Methods
Banked equine CSF samples from horses with neurologic disease that underwent a complete neurologic examination and postmortem diagnosis confirmation of CVSM or eNAD/EDM or from control horses were included. Cytokines were measured with an equine-specific cytokine/chemokine magnetic bead multiplex panel (23-cytokine multiplex). Results were compared between groups, and correlations with clinical parameters were evaluated.
Results
Cerebrospinal fluid samples from 35 horses with CVSM, 35 horses with eNAD/EDM, and 8 control horses were analyzed. Most cytokines analyzed were below the lower limit of detection in the majority of samples. Eotaxin, IL-10, interferon-γ–induced protein 10, granulocyte colony-stimulating factor, and tumor necrosis factor–α were detectable in 5 or more samples; however, concentrations were not different between groups. Increasing sample volume or using a commercial protein-concentrating column did not enhance cytokine recovery. In horses with eNAD/EDM, IL-10 concentrations correlated with CSF phosphorylated neurofilament heavy concentrations.
Conclusions
This commercial cytokine assay was unable to distinguish between CVSM and eNAD/EDM based on CSF cytokine profiles in this population. Clinical Relevance Optimization of a more sensitive assay is warranted as CSF cytokine concentrations have high potential to be used as biomarkers to characterize neuroinflammation in equine neurological diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Studies, School of Veterinary Medicine, New Bolton Center, University of Pennsylvania, Kennett Square, PA.
- Equine Diagnostic Solutions, Lexington, KY.
- University of Kentucky Veterinary Diagnostic Laboratory, Lexington, KY.
- Rood & Riddle Equine Hospital, Lexington, KY.
ORCID-Profile: Flavie Payette
Zitieren
APA
Payette, F., Kulp, J. C., Graves, A., Janes, J., Morrow, J., Orr, K., Reed, S., Ruby, R., Stefanovski, D., & Johnson, A. L. (2025). Commercial cytokine assay on equine cerebrospinal fluid does not distinguish equine degenerative myeloencephalopathy from cervical vertebral stenotic myelopathy. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.25.06.0212
Vancouver
Payette F, Kulp JC, Graves A, Janes J, Morrow J, Orr K, et al. Commercial cytokine assay on equine cerebrospinal fluid does not distinguish equine degenerative myeloencephalopathy from cervical vertebral stenotic myelopathy. American Journal of Veterinary Research. 2025. doi:10.2460/ajvr.25.06.0212
BibTeX
@article{Payette2025,
author = {Payette, Flavie and Kulp, Jeaneen C and Graves, Amy and Janes, Jennifer and Morrow, Jennifer and Orr, Kindra and Reed, Stephen and Ruby, Rebecca and Stefanovski, Darko and Johnson, Amy L},
title = {Commercial cytokine assay on equine cerebrospinal fluid does not distinguish equine degenerative myeloencephalopathy from cervical vertebral stenotic myelopathy},
journal = {American Journal of Veterinary Research},
year = {2025},
doi = {10.2460/ajvr.25.06.0212}
}
EUVIMED